MAA
ENTA icon

Managed Account Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Managed Account Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$14.1M Sell
313,543
-968
-0.3% -$37.7K 0.01% 917
2015
Q1 		$9.63M Buy
314,511
+189,193
+151% +$7.36M 0.01% 1093
2014
Q4 		$6.37M Buy
125,318
+19,951
+19% +$893K 0.01% 1281
2014
Q3 		$4.17M Buy
105,367
+13,195
+14% +$526K ﹤0.01% 1463
2014
Q2 		$3.97M Buy
92,172
+18,037
+24% +$688K ﹤0.01% 1488
2014
Q1 		$2.96M Buy
+74,135
New +$2.69M ﹤0.01% 1569

Other funds holding ENTA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MVM
McClain Value Management New Canaan, Connecticut $50.9M AUM 16.06% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Managed Account Advisors's ENTA Position: Q2 2015 in Review

Managed Account Advisors reduced its Enanta Pharmaceuticals (ENTA) stake by 0.31% in Q2 2015, selling an estimated $37.7K and leaving 313,543 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #917.

Managed Account Advisors first reported a position in ENTA in Q1 2014 and has held it in 6 quarters since. 131 funds tracked by Wall St. Rank hold ENTA as of Q2 2015.

  • Managed Account Advisors held 313,543 shares of Enanta Pharmaceuticals worth $14.1M as of Q2 2015.
  • Managed Account Advisors sold 968 Enanta Pharmaceuticals shares in Q2 2015, an estimated $37.7K.
  • Enanta Pharmaceuticals made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #917 holding.
  • Managed Account Advisors first reported a position in Enanta Pharmaceuticals in Q1 2014 and has held it in 6 quarters since.
  • 131 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.